HIV News and Research

RSS

Virginia Mason wins Healthgrades Outstanding Patient Experience Award for second consecutive year

Virginia Mason was today named a recipient of Healthgrades Outstanding Patient Experience Award for the second consecutive year. This distinction places it among the top 10 percent of hospitals in the nation for patient experience.

8 Apr 2014

African Americans are at higher risk of developing Alzheimer's disease than white population

A new study by researchers at Rush University Medical Center reviews research that suggests that the risk for developing Alzheimer's disease among older African Americans may be two to three times greater than in the non-Hispanic white population and that they differ from the non-Hispanic white population in risk factors and disease manifestation.

8 Apr 2014

Bristol-Myers Squibb submits NDAs to FDA for treatment of genotype 1b hepatitis C

Bristol-Myers Squibb Company (NYSE:BMY) announced today that they have submitted new drug applications (NDAs) with the U.S. Food and Drug Administration (FDA) for the investigational products daclatasvir (DCV), an NS5A replication complex inhibitor, and asunaprevir (ASV), a NS3 protease inhibitor.

8 Apr 2014

Bezos family gifts $20M to Fred Hutchinson scientists for development of novel cancer immunotherapies

Fred Hutchinson Cancer Research Center scientists striving for new cancer cures - and the patients who stand to benefit from them - got an enormous boost today when the Bezos family committed $20 million to support the development of novel cancer immunotherapies. It is the largest single contribution in Fred Hutch's history.

8 Apr 2014

Added benefit of antiviral drug combination in treatment of HIV-1 patients is not proven

The German Institute for Quality and Efficiency in Health Care (IQWiG) reassessed the antiviral drug combination rilpivirine/emtricitabine/tenofovir. In early 2012, the combination was approved for the treatment of adults infected with human immunodeficiency virus type 1 (HIV-1) who have not received previous antiretroviral treatment.

8 Apr 2014

Brown University researchers awarded USAID grant to test community-based breastfeeding support initiative

Kenya's government has made significant progress recently in developing programs to promote breastfeeding among mothers who deliver at the hospital but about 60 percent of the nation's babies are born outside a health care facility.

8 Apr 2014

Transplant drugs may help defeat HIV

Drugs that are currently given to prevent organ rejection in patients who have received a transplant may offer a new approach to curing HIV, say researchers.

3 Apr 2014

New cluster of viral meningitis cases found among Los Angeles area gay men

In response to reports of a new cluster of viral meningitis cases found among Los Angeles area gay men and men-who-have-sex-with-men (MSM), Los Angeles County Public Health Department officials are expected to release an official statement later today in which they will recommend that HIV-positive MSM and high-risk HIV-negative MSM be vaccinated against the infection.

3 Apr 2014

JPIAMR outlines steps to minimise antimicrobial resistance

Antibiotics have saved millions of lives from once deadly infectious diseases. But, misuse of antibiotics and other antimicrobials in humans and animals has led to bacteria evolving resistance.

3 Apr 2014

Research findings suggest new strategy in fight against HIV infection

New research suggests that drugs commonly used to prevent organ rejection after transplantation may also be helpful for combating HIV. The findings, which are published in the American Journal of Transplantation, suggest a new strategy in the fight against HIV and AIDS.

3 Apr 2014

ABL enters into licensing agreement with CRP-Santé for COMET software

Advanced Biological Laboratories (ABL) S.A., a Luxembourg-based company today announced that it has entered into an exclusive worldwide licensing agreement with CRP-Santé, a Luxembourg-based public research center active in the field of clinically oriented biomedical research, for its COMET (COntext-based Modeling for Expeditious Typing) software, a tool designed to rapidly analyze and optimally subtype large genetic data sets arising from epidemiological or antiretroviral resistance in the human immunodeficiency virus (HIV) and hepatitis C virus (HCV) fields.

2 Apr 2014

Study shows important parallels between epidemic of HIV/AIDS and opioid addiction

There are important parallels between the early years of the HIV/AIDS epidemic and the current epidemic of opioid addiction - ones that could trigger a significant shift in opioid addiction prevention, diagnosis and treatment.

2 Apr 2014

Teva granted certiorari petition related to Mylan's ANDA for Copaxone

Mylan Inc. announced that today the Supreme Court of the United States granted certiorari in Mylan's patent litigation against Teva relating to Mylan's Abbreviated New Drug Application (ANDA) for glatiramer acetate (Copaxone).

1 Apr 2014

Novel proteins may lead to new ways to combat venereal disease

Researchers at Oregon State University have discovered novel proteins in, or on the surface of the bacteria that causes gonorrhea, which offer a promising new avenue of attack against a venereal disease that is showing increased resistance to the antibiotics used to treat it.

1 Apr 2014

Men with long-term HIV infections at higher risk of developing plaque in their coronary arteries

Men with long-term HIV infections are at higher risk than uninfected men of developing plaque in their coronary arteries, regardless of their other risk factors for coronary artery disease, according to results of a study led by Johns Hopkins researchers. A report on the research appears in the April 1 issue of Annals of Internal Medicine.

1 Apr 2014

CytRx’s aldoxorubicin receives European orphan medicinal product designation for treatment of advanced soft tissue sarcomas

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that aldoxorubicin has received orphan medicinal product designation from the European Commission for the treatment of advanced soft tissue sarcomas. The designation is to encourage the development of drugs which may provide significant benefit to patients suffering from rare diseases.

31 Mar 2014

Researchers find good bacteria that protect women from HIV infection

Researchers at the University of Texas Medical Branch at Galveston by growing vaginal skin cells outside the body and studying the way they interact with "good and bad" bacteria, think they may be able to better identify the good bacteria that protect women from HIV infection and other sexually transmitted infections.

28 Mar 2014

New approach can improve patient outcomes, reduce complications in complex spine surgeries

A new team approach has improved safety-reducing rates of major complications by two thirds-for complex spinal reconstructive surgery for spinal deformity in adult Group Health patients at Virginia Mason Hospital & Seattle Medical Center.

27 Mar 2014

Cytrx releases statement in response to two recent lawsuits

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today issued the following statement in response to two recent lawsuits filed in the name of CytRx shareholders:

27 Mar 2014

Jury returns verdict in favor of Mylan in breach of contract case against GSK

Mylan Inc. today announced that, after a trial in the United States District Court for the District of New Jersey, a jury returned a verdict in favor of Mylan in its breach of contract lawsuit against GlaxoSmithKline (GSK) relating to Paroxetine Hydrochloride Extended-release (ER) Tablets.

27 Mar 2014

HIV News and Research

Virginia Mason wins Healthgrades Outstanding Patient Experience Award for second consecutive year

African Americans are at higher risk of developing Alzheimer's disease than white population

Bristol-Myers Squibb submits NDAs to FDA for treatment of genotype 1b hepatitis C

Bezos family gifts $20M to Fred Hutchinson scientists for development of novel cancer immunotherapies

Added benefit of antiviral drug combination in treatment of HIV-1 patients is not proven

Brown University researchers awarded USAID grant to test community-based breastfeeding support initiative

Transplant drugs may help defeat HIV

New cluster of viral meningitis cases found among Los Angeles area gay men

JPIAMR outlines steps to minimise antimicrobial resistance

Research findings suggest new strategy in fight against HIV infection

ABL enters into licensing agreement with CRP-Santé for COMET software

Study shows important parallels between epidemic of HIV/AIDS and opioid addiction

Teva granted certiorari petition related to Mylan's ANDA for Copaxone

Novel proteins may lead to new ways to combat venereal disease

Men with long-term HIV infections at higher risk of developing plaque in their coronary arteries

CytRx’s aldoxorubicin receives European orphan medicinal product designation for treatment of advanced soft tissue sarcomas

Researchers find good bacteria that protect women from HIV infection

New approach can improve patient outcomes, reduce complications in complex spine surgeries

Cytrx releases statement in response to two recent lawsuits

Jury returns verdict in favor of Mylan in breach of contract case against GSK

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News